Impact of vascular endothelial growth factor-C and -D expression in human pancreatic cancer: its relationship to lymph node metastasis
about
Molecular mechanism underlying lymphatic metastasis in pancreatic cancerExpression of vascular endothelial growth factors A and C in human pancreatic cancer.Membrane proteomic analysis of pancreatic cancer cells.Prognostic and predictive blood-based biomarkers in patients with advanced pancreatic cancer: results from CALGB80303 (Alliance)VEGF-D-induced draining lymphatic enlargement and tumor lymphangiogenesis promote lymph node metastasis in a xenograft model of ovarian carcinomaDistinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis.ZD6474--a novel inhibitor of VEGFR and EGFR tyrosine kinase activitySTAT5b as molecular target in pancreatic cancer--inhibition of tumor growth, angiogenesis, and metastases.Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patientsHeparanase regulates in vitro VEGF-C expression and its clinical significance to pancreatic ductal cell adenocarcinoma.Hypoxia and angiogenesis in pancreatic cancer.Clinical significance of midkine expression in pancreatic head carcinoma.CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer.Correlation of vascular endothelial growth factor-D expression and VEGFR-3-positive vessel density with lymph node metastasis in gastric carcinoma.Molecular targeted therapies for pancreatic cancer.Molecular prognostic factors in patients with pancreatic cancer.Filamin C promotes lymphatic invasion and lymphatic metastasis and increases cell motility by regulating Rho GTPase in esophageal squamous cell carcinomaMeta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer.The extent of retraction clefts correlates with lymphatic vessel density and VEGF-C expression and predicts nodal metastasis and poor prognosis in early-stage breast carcinoma.VEGF Expression in Pancreatic Cancer and Other Malignancies: A Review of the Literature.The lymphatic system and pancreatic cancer.Combined targeting of TGF-β, EGFR and HER2 suppresses lymphangiogenesis and metastasis in a pancreatic cancer model.Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis.VEGF receptor-2-specific signaling mediated by VEGF-E induces hemangioma-like lesions in normal and in malignant tissue.Effect of CCR7, CXCR4 and VEGF-C on the lymph node metastasis of human pancreatic ductal adenocarcinoma.Decreased serum vascular endothelial growth factor-D levels in metastatic patients with differentiated thyroid carcinoma.Clinical significance of folate receptor β-expressing tumor-associated macrophages in pancreatic cancer.Expression of VEGF-D in epithelial ovarian cancer and its relationship to lymphatic metastasis.Biomimetic and enzyme-responsive dynamic hydrogels for studying cell-matrix interactions in pancreatic ductal adenocarcinoma.Significance of Vascular Endothelial Growth Factor (VEGF)-C and VEGF-D in the Progression of Cutaneous Melanoma.
P2860
Q26999345-F9A4EB86-23AA-4A13-A1B7-32F9FC9155CCQ33788147-A25FFB6D-73D5-4BE0-B767-48C083BF29FEQ34173879-2ADB61D3-806D-4D46-BC84-47B618B0ED1AQ34447921-F559C22F-23DA-467D-A9C1-2FC2C765CE20Q35087391-F3122E48-36F3-4052-98D2-A6B0B491BBB8Q35691635-2D6195DD-22DA-4F97-930A-DF9520C28C6CQ36146888-7FE831B3-8C1E-487E-8668-373D8435C12AQ36343768-176C940F-633A-474B-B614-570F5DD14FDCQ36402488-B756E6E6-6EDE-4A86-B9B5-76C893E5667FQ36524769-489C7020-6271-48D8-8447-6801CFA4CA5FQ36572752-977B997A-64B6-4263-BB01-9112A6064BB3Q36610901-3B5289C8-0187-4C5B-8A0F-B4786DA35BBDQ36615659-02F468EA-21E8-4EB0-93A1-AF348B884421Q36854026-D05F7071-3D4B-4E6B-8A82-C001C1F97701Q36944441-AA3065F6-C837-48F7-AE91-6FBCE6B4925BQ37004734-52A7A93D-9167-48E6-B884-B4F970765E78Q37701605-05962CD4-6908-4F51-8034-7677180DD3F5Q37859255-1B514D26-006F-42F0-908E-60C6A3DAD421Q37948581-A7C2FDFA-EE3F-4E8B-A988-59FF3BFCF34AQ38681382-1C7EBC0D-9ACA-4360-9CC9-42CFE1D710B9Q38689578-56B4BC17-CF7E-4B38-BEC4-782D33B28462Q39706220-2447CE6F-0A46-4515-8183-418E57A89745Q40147274-A26369F8-259A-45A0-83A5-716ADF52547BQ40821361-F9F72903-4A64-4F26-9D23-C0558CD560D9Q42149105-BCDD18B9-4897-41DC-93E3-DC425F8A021AQ42491935-F7073000-0D9C-4433-8ABC-6BDF8A6BE750Q43535475-A3BADF6F-E2D0-4BC0-B6A9-C061B9198769Q43772841-840BE631-532A-43B4-B941-250E9198E23AQ49900777-ACFE9030-D561-48F7-A8E5-AED46CFE49CFQ53530314-A57CE53D-7BF9-4BE3-90CB-580C16768E04
P2860
Impact of vascular endothelial growth factor-C and -D expression in human pancreatic cancer: its relationship to lymph node metastasis
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Impact of vascular endothelial ...... nship to lymph node metastasis
@ast
Impact of vascular endothelial ...... nship to lymph node metastasis
@en
Impact of vascular endothelial ...... nship to lymph node metastasis
@nl
type
label
Impact of vascular endothelial ...... nship to lymph node metastasis
@ast
Impact of vascular endothelial ...... nship to lymph node metastasis
@en
Impact of vascular endothelial ...... nship to lymph node metastasis
@nl
prefLabel
Impact of vascular endothelial ...... nship to lymph node metastasis
@ast
Impact of vascular endothelial ...... nship to lymph node metastasis
@en
Impact of vascular endothelial ...... nship to lymph node metastasis
@nl
P2093
P1476
Impact of vascular endothelial ...... nship to lymph node metastasis
@en
P2093
Hiroshi Kurahara
Hiroyuki Shinchi
Kousei Maemura
Shoji Natsugoe
Sonshin Takao
Takashi Aikou
P304
P356
10.1158/1078-0432.CCR-04-0379
P407
P577
2004-12-15T00:00:00Z